Yungjin Pharm Co Ltd (003520) — Capital Reinvestment Ratio
Yungjin Pharm Co Ltd (003520) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.00 Billion) in capital expenditures (₩2.16 Billion). Check Yungjin Pharm Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yungjin Pharm Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Yungjin Pharm Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 003520 cash flow conversion.
Annual Capital Reinvestment Ratio for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Yungjin Pharm Co Ltd from 2013 to 2024. See Yungjin Pharm Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | ₩21.74 Billion | ₩21.61 Billion | ▼ -26.5% |
| 2021 | 1.35x | ₩8.37 Billion | ₩11.32 Billion | ▲ +211.1% |
| 2020 | 0.43x | ₩14.50 Billion | ₩6.30 Billion | ▼ -61.0% |
| 2019 | 1.12x | ₩9.28 Billion | ₩10.36 Billion | ▼ -69.8% |
| 2018 | 3.69x | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.9% |
| 2017 | 3.36x | ₩3.15 Billion | ₩10.59 Billion | ▲ +122.8% |
| 2016 | 1.51x | ₩3.11 Billion | ₩4.69 Billion | ▼ -3.5% |
| 2015 | 1.56x | ₩8.80 Billion | ₩13.75 Billion | ▼ -14.1% |
| 2014 | 1.82x | ₩6.22 Billion | ₩11.30 Billion | ▲ +63.3% |
| 2013 | 1.11x | ₩5.95 Billion | ₩6.63 Billion | — |